Pediculosis Capitis
📧 Sign up to get email alerts when something new happens for Pediculosis Capitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Comparative Study for the Evaluation of a New Medical Device Shampoo on the Treatment of Head Lice Infestation [NA]
A clinical trial registry entry for a comparative evaluation of a new medical device shampoo to treat Pediculosis capitis, with recruitment …
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Efficacy and Safetyof a Medical Device With a Physical Mode of Action (X92001919) Versus Paranix Anti-lice Shampoo. [NA]
Clinical trial comparing a medical device with physical action (X92001919) to Paranix Anti-lice Shampoo for head lice, currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation [Phase 4]
A Phase 4 study evaluating the efficacy and safety of a leave-in spray for head lice infestation (Pediculosis capitis) has completed with re…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product. [NA]
Clinical trial completed evaluating a water-soluble head lice product for efficacy and safety; results posted in 2022.
-
FDA approval · 2021-05-28FDA Approved: SKLICE — Supplemental Application (Azurity Pharmaceuticals)
The FDA approved a supplemental application for SKLICE (ivermectin), manufactured by Azurity Pharmaceuticals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2021-04-28FDA Approved: NATROBA — Supplemental Application (Cipher Pharmaceuticals Inc.)
FDA approved a supplemental application for NATROBA (spinosad) by Cipher Pharmaceuticals to update the product labeling.
-
FDA approval · 2020-10-27FDA Approved: SKLICE — Supplemental Application (Azurity Pharmaceuticals)
FDA approved a supplemental application for SKLICE (ivermectin) by Azurity Pharmaceuticals to authorize changes related to the product's use…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% [Phase 1]
This updates the completion of a Phase 1 bioequivalence study comparing two formulations of ivermectin lotion 0.5% for head lice infestation…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos [Phase 2]
Phase 2 trial assessing the efficacy and safety of topical 0.5% ivermectin lotion for treating pediculosis capitis (head lice) in Filipino p…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: A Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit on Pediatric and Adult Subjects [NA]
This document reports a completed clinical trial evaluating the efficacy of the Resultz Lice and Egg Elimination Kit for treating head lice …
-
FDA approval · 2017-06-16FDA Approved: SKLICE — Supplemental Application (Azurity Pharmaceuticals)
The FDA approved a supplemental application for SKLICE (ivermectin) submitted by Azurity Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Pilot Dose Ranging Study of Spinosad Creme Rinse [Phase 2]
A Phase 2 pilot dose-ranging study evaluating Spinosad Creme Rinse for pediculosis capitis (head lice) has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Cocamide DEA vs Permethrin for Head Lice [Phase 3]
Phase 3 trial comparing cocamide DEA to permethrin for head lice (Pediculosis Capitis / Head Lice Infestation) was terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin [NA]
A completed trial evaluated the efficacy and safety of Licefreee Spray versus Nix 1% Permethrin for treating Pediculosis capitis, with resul…
-
FDA approval · 2014-12-30FDA Approved: NATROBA — Supplemental Application (Cipher Pharmaceuticals Inc.)
The FDA approved a supplemental application for NATROBA (spinosad) filed by Cipher Pharmaceuticals Inc., updating the labeling for the exist…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice [Phase 3]
This Phase 3 trial evaluated the efficacy, safety, and tolerability of a novel malathion formulation for head lice in patients aged 2 years …
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice [Phase 1]
Phase 1 pharmacokinetics study evaluating malathion gel 0.5% and malathion 0.5% lotion (Ovide) in patients with head lice has been completed…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation [Phase 4]
Phase 4 pharmacokinetic and tolerance study of Natroba (spinosad) topical suspension in pediatric patients with active head lice infestation…
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice [Phase 3]
Phase 3 trial evaluating the safety and efficacy of NatrOVA Creme Rinse 1% and NIX Creme Rinse for treating head lice in individuals aged 6 …
-
FDA approval · 2012-05-23FDA Approved: OVIDE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA approved the original application for OVIDE, a topical malathion lotion for head lice infestation.
-
CLINICAL_TRIALS trial_result · 2012-04-25Clinical Trial Update: A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age [Phase 1]
Phase 1 pharmacokinetics study evaluating a lice treatment in children aged 6 months to 3 years with head lice; the study status is complete…
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects [Phase 3]
Phase 3 study comparing 0.5% ivermectin cream to placebo for head lice infestation; completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation [Phase 3]
This Phase 3 study evaluated the safety and efficacy of 0.5% ivermectin cream versus vehicle in treating Pediculosis capitis (head lice); th…
-
FDA approval · 2012-02-07FDA Approved: SKLICE — Original Application (Azurity Pharmaceuticals)
FDA approved SKLICE (ivermectin) via an Original Application NDA for topical treatment of head lice infestations in patients aged 6 months a…
-
CLINICAL_TRIALS trial_result · 2011-08-22Clinical Trial Update: Ivermectin in the Treatment of Head Lice [Phase 3]
Phase 3 trial evaluating ivermectin for pediculosis capitis (head lice) treatment has completed.